134 related articles for article (PubMed ID: 33345726)
1. Targeting a conserved pocket (n-octyl-β-D-glucoside) on the dengue virus envelope protein by small bioactive molecule inhibitors.
Naresh P; Selvaraj A; Shyam Sundar P; Murugesan S; Sathianarayanan S; Namboori P K K; Jubie S
J Biomol Struct Dyn; 2022 Jul; 40(11):4866-4878. PubMed ID: 33345726
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
Aarthy M; Singh SK
Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
[TBL] [Abstract][Full Text] [Related]
3. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
[TBL] [Abstract][Full Text] [Related]
5. A small molecule fusion inhibitor of dengue virus.
Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
[TBL] [Abstract][Full Text] [Related]
6. Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein.
Amir-Hassan A; Lee VS; Baharuddin A; Othman S; Xu Y; Huang M; Yusof R; Rahman NA; Othman R
J Mol Graph Model; 2017 Jun; 74():273-287. PubMed ID: 28458006
[TBL] [Abstract][Full Text] [Related]
7. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.
Zhou Z; Khaliq M; Suk JE; Patkar C; Li L; Kuhn RJ; Post CB
ACS Chem Biol; 2008 Dec; 3(12):765-75. PubMed ID: 19053243
[TBL] [Abstract][Full Text] [Related]
8. Receptor-Guided De Novo Design of Dengue Envelope Protein Inhibitors.
Desai VH; Kumar SP; Pandya HA; Solanki HA
Appl Biochem Biotechnol; 2015 Oct; 177(4):861-78. PubMed ID: 26299376
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
[TBL] [Abstract][Full Text] [Related]
10. Targeting the dengue β-OG with serotype-specific alkaloid virtual leads.
Gangopadhyay A; Chakraborty HJ; Datta A
J Mol Graph Model; 2017 May; 73():129-142. PubMed ID: 28279821
[TBL] [Abstract][Full Text] [Related]
11. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
12. Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2.
Tambunan US; Zahroh H; Parikesit AA; Idrus S; Kerami D
Drug Target Insights; 2015; 9():33-49. PubMed ID: 26617459
[TBL] [Abstract][Full Text] [Related]
13. Structure-based screening and validation of potential dengue virus inhibitors through classical and QM/MM affinity estimation.
Ahmed M; Kumar A; Hobman TC; Barakat K
J Mol Graph Model; 2019 Jul; 90():128-143. PubMed ID: 31082639
[TBL] [Abstract][Full Text] [Related]
14. Targeting domain-III hinging of dengue envelope (DENV-2) protein by MD simulations, docking and free energy calculations.
Dubey KD; Tiwari G; Ojha RP
J Mol Model; 2017 Apr; 23(4):102. PubMed ID: 28255859
[TBL] [Abstract][Full Text] [Related]
15. Identification of sequence motifs involved in Dengue virus-host interactions.
Asnet Mary J; Paramasivan R; Shenbagarathai R
J Biomol Struct Dyn; 2016; 34(3):676-87. PubMed ID: 25905427
[TBL] [Abstract][Full Text] [Related]
16. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
17. Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics.
Parikesit AA; Kinanty ; Tambunan US
Pak J Biol Sci; 2013 Dec; 16(24):1836-48. PubMed ID: 24516999
[TBL] [Abstract][Full Text] [Related]
18. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
19. Epitopes based drug design for dengue virus envelope protein: A computational approach.
Wadood A; Mehmood A; Khan H; Ilyas M; Ahmad A; Alarjah M; Abu-Izneid T
Comput Biol Chem; 2017 Dec; 71():152-160. PubMed ID: 29096381
[TBL] [Abstract][Full Text] [Related]
20. Interaction and inhibition of dengue envelope glycoprotein with mammalian receptor DC-sign, an in-silico approach.
Shah M; Wadood A; Rahman Z; Husnain T
PLoS One; 2013; 8(3):e59211. PubMed ID: 23527139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
